SCHEMBL24308138

SCHEMBL24308138

CNC(CCCCNC(=O)C(C)C)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.41
▸ SIRT1 Q96EB6 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SIRT5 Q9NXA8 2/20 0.40
▸ DPP7 Q9UHL4 2/20 0.40
▸ GNAI3 P08754 1/20 0.39
▸ GNAO1 P09471 1/20 0.39
▸ GNAI1 P63096 1/20 0.39
▸ CACNA1B Q00975 2/20 0.37
▸ RRM1 P23921 1/20 0.37
▸ ALB P02768 1/20 0.36
▸ TLR2 O60603 2/20 0.36
▸ ALDH1A2 O94788 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ ALDH2 P05091 1/20 0.36
▸ ALDH1A3 P47895 1/20 0.36
▸ FOLH1 Q04609 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26379449 0.85 SIRT6 (0.40) SIRT6SIRT1CYP2D6CYP2C9CYP2C19
SCHEMBL16384377 0.85 CYP2D6 (0.45) SIRT6SIRT1CYP2D6CYP2C9CYP2C19
SCHEMBL20414861 0.83 KDM4E (0.52) SIRT6SIRT1SIRT5DPP7GNAI3
SCHEMBL8106503 0.83 KDM4E (0.52) SIRT6SIRT1SIRT5DPP7GNAI3
SCHEMBL20411608 0.83 KDM4E (0.52) SIRT6SIRT1SIRT5DPP7GNAI3
SCHEMBL20411605 0.83 KDM4E (0.52) SIRT6SIRT1SIRT5DPP7GNAI3
SCHEMBL16283730 0.83 NOD1 (0.50) SIRT6SIRT1CYP2D6CYP2C9CYP2C19
SCHEMBL14148761 0.81 FNTA (0.48) SIRT6SIRT1SIRT5DPP7GNAI3
SCHEMBL16283727 0.81 TLR2 (0.45) SIRT6SIRT1CYP2D6CYP2C9CYP2C19
SCHEMBL19472246 0.81 KDM4E (0.55) SIRT6SIRT1SIRT5GNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331801-A1 IL-2R-BETA-GAMMA BINDING COMPOUNDS MEDIKINE, INC. (US) 2023-10-19 — — US disclosed
US-20230312653-A1 CYCLIC CELL PENETRATING PEPTIDES ENTRADA THERAPEUTICS, INC. 2023-10-05 — — US disclosed
US-11718654-B2 IL-2R-βγ binding compounds MEDIKINE, INC. (US) 2023-08-08 — — US disclosed
US-20220119493-A1 IL-7R-ALPHA BINDING COMPOUNDS SAMSARA BIOCAPITAL, L.P. 2022-04-21 — — US disclosed
US-20220119492-A1 IL-2R-BETA-GAMMA BINDING COMPOUNDS AND USES THEREOF JEFFREY W. AND CHRISTINA R. BIRD TRUST U/A/D 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331801-A1 IL-2R-BETA-GAMMA BINDING COMPOUNDS IL2RA, IL2, IL15RA SIRT6 4196/4885SIRT1 3438/4885CYP2D6 2614/4885
US-20230312653-A1 CYCLIC CELL PENETRATING PEPTIDES SLC47A1, SLC47A2, VIP SIRT6 3125/4885SIRT1 3781/4885CYP2D6 4762/4885
US-11718654-B2 IL-2R-βγ binding compounds IL2RA, IL2, IL1RN SIRT6 4125/4885SIRT1 3372/4885CYP2D6 3241/4885
US-20220119492-A1 IL-2R-BETA-GAMMA BINDING COMPOUNDS AND USES THEREOF IL2RA, IL2, IL15RA SIRT6 4345/4885SIRT1 3643/4885CYP2D6 3475/4885
US-20220119493-A1 IL-7R-ALPHA BINDING COMPOUNDS IL2RA, IL6ST, IL1RN SIRT6 3038/4885SIRT1 3580/4885CYP2D6 2851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback